1001 related articles for article (PubMed ID: 28619995)
1. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995
[TBL] [Abstract][Full Text] [Related]
2. Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.
Maruyama H; Dewachter C; Belhaj A; Rondelet B; Sakai S; Remmelink M; Vachiery JL; Naeije R; Dewachter L
J Heart Lung Transplant; 2015 Mar; 34(3):468-78. PubMed ID: 25447587
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor-β(1) represses bone morphogenetic protein-mediated Smad signaling in pulmonary artery smooth muscle cells via Smad3.
Upton PD; Davies RJ; Tajsic T; Morrell NW
Am J Respir Cell Mol Biol; 2013 Dec; 49(6):1135-45. PubMed ID: 23937428
[TBL] [Abstract][Full Text] [Related]
4. BMPRII influences the response of pulmonary microvascular endothelial cells to inflammatory mediators.
Vengethasamy L; Hautefort A; Tielemans B; Belge C; Perros F; Verleden S; Fadel E; Van Raemdonck D; Delcroix M; Quarck R
Pflugers Arch; 2016 Nov; 468(11-12):1969-1983. PubMed ID: 27816994
[TBL] [Abstract][Full Text] [Related]
5. Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.
Meloche J; Courchesne A; Barrier M; Carter S; Bisserier M; Paulin R; Lauzon-Joset JF; Breuils-Bonnet S; Tremblay É; Biardel S; Racine C; Courture C; Bonnet P; Majka SM; Deshaies Y; Picard F; Provencher S; Bonnet S
J Am Heart Assoc; 2013 Jan; 2(1):e005157. PubMed ID: 23525442
[TBL] [Abstract][Full Text] [Related]
6. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation.
Nie X; Tan J; Dai Y; Liu Y; Zou J; Sun J; Ye S; Shen C; Fan L; Chen J; Bian JS
J Mol Cell Cardiol; 2018 Mar; 116():41-56. PubMed ID: 29374556
[TBL] [Abstract][Full Text] [Related]
7. Deletion of the sequence encoding the tail domain of the bone morphogenetic protein type 2 receptor reveals a bone morphogenetic protein 7-specific gain of function.
Leyton PA; Beppu H; Pappas A; Martyn TM; Derwall M; Baron DM; Galdos R; Bloch DB; Bloch KD
PLoS One; 2013; 8(10):e76947. PubMed ID: 24116187
[TBL] [Abstract][Full Text] [Related]
8. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension.
Gomez-Puerto MC; van Zuijen I; Huang CJ; Szulcek R; Pan X; van Dinther MA; Kurakula K; Wiesmeijer CC; Goumans MJ; Bogaard HJ; Morrell NW; Rana AA; Ten Dijke P
J Pathol; 2019 Nov; 249(3):356-367. PubMed ID: 31257577
[TBL] [Abstract][Full Text] [Related]
9. Sildenafil potentiates bone morphogenetic protein signaling in pulmonary arterial smooth muscle cells and in experimental pulmonary hypertension.
Yang J; Li X; Al-Lamki RS; Wu C; Weiss A; Berk J; Schermuly RT; Morrell NW
Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):34-42. PubMed ID: 23139294
[TBL] [Abstract][Full Text] [Related]
10. Reduced BMPR2 expression induces GM-CSF translation and macrophage recruitment in humans and mice to exacerbate pulmonary hypertension.
Sawada H; Saito T; Nickel NP; Alastalo TP; Glotzbach JP; Chan R; Haghighat L; Fuchs G; Januszyk M; Cao A; Lai YJ; Perez Vde J; Kim YM; Wang L; Chen PI; Spiekerkoetter E; Mitani Y; Gurtner GC; Sarnow P; Rabinovitch M
J Exp Med; 2014 Feb; 211(2):263-80. PubMed ID: 24446489
[TBL] [Abstract][Full Text] [Related]
11. BMPR2 gene delivery reduces mutation-related PAH and counteracts TGF-β-mediated pulmonary cell signalling.
Feng F; Harper RL; Reynolds PN
Respirology; 2016 Apr; 21(3):526-32. PubMed ID: 26689975
[TBL] [Abstract][Full Text] [Related]
12. Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension.
Hautefort A; Mendes-Ferreira P; Sabourin J; Manaud G; Bertero T; Rucker-Martin C; Riou M; Adão R; Manoury B; Lambert M; Boet A; Lecerf F; Domergue V; Brás-Silva C; Gomez AM; Montani D; Girerd B; Humbert M; Antigny F; Perros F
Circulation; 2019 Feb; 139(7):932-948. PubMed ID: 30586714
[TBL] [Abstract][Full Text] [Related]
13. Correction of nonsense BMPR2 and SMAD9 mutations by ataluren in pulmonary arterial hypertension.
Drake KM; Dunmore BJ; McNelly LN; Morrell NW; Aldred MA
Am J Respir Cell Mol Biol; 2013 Sep; 49(3):403-9. PubMed ID: 23590310
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells.
Yu PB; Beppu H; Kawai N; Li E; Bloch KD
J Biol Chem; 2005 Jul; 280(26):24443-50. PubMed ID: 15883158
[TBL] [Abstract][Full Text] [Related]
15. BMP type II receptor deficiency confers resistance to growth inhibition by TGF-β in pulmonary artery smooth muscle cells: role of proinflammatory cytokines.
Davies RJ; Holmes AM; Deighton J; Long L; Yang X; Barker L; Walker C; Budd DC; Upton PD; Morrell NW
Am J Physiol Lung Cell Mol Physiol; 2012 Mar; 302(6):L604-15. PubMed ID: 22227206
[TBL] [Abstract][Full Text] [Related]
16. The transforming growth factor-β-bone morphogenetic protein type signalling pathway in pulmonary vascular homeostasis and disease.
Upton PD; Morrell NW
Exp Physiol; 2013 Aug; 98(8):1262-6. PubMed ID: 23645549
[TBL] [Abstract][Full Text] [Related]
17. Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation.
Tian W; Jiang X; Sung YK; Shuffle E; Wu TH; Kao PN; Tu AB; Dorfmüller P; Cao A; Wang L; Peng G; Kim Y; Zhang P; Chappell J; Pasupneti S; Dahms P; Maguire P; Chaib H; Zamanian R; Peters-Golden M; Snyder MP; Voelkel NF; Humbert M; Rabinovitch M; Nicolls MR
Circulation; 2019 Oct; 140(17):1409-1425. PubMed ID: 31462075
[TBL] [Abstract][Full Text] [Related]
18. Dysregulated Smooth Muscle Cell BMPR2-ARRB2 Axis Causes Pulmonary Hypertension.
Wang L; Moonen JR; Cao A; Isobe S; Li CG; Tojais NF; Taylor S; Marciano DP; Chen PI; Gu M; Li D; Harper RL; El-Bizri N; Kim YM; Stankunas K; Rabinovitch M
Circ Res; 2023 Mar; 132(5):545-564. PubMed ID: 36744494
[TBL] [Abstract][Full Text] [Related]
19. SMAD1 deficiency in either endothelial or smooth muscle cells can predispose mice to pulmonary hypertension.
Han C; Hong KH; Kim YH; Kim MJ; Song C; Kim MJ; Kim SJ; Raizada MK; Oh SP
Hypertension; 2013 May; 61(5):1044-52. PubMed ID: 23478097
[TBL] [Abstract][Full Text] [Related]
20. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
Cheng G; Wang X; Li Y; He L
Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
